Stellar Health has announced a partnership with North Collaborative Care (NCC) ACO, one of the largest accountable care organizations in Minnesota, focused driving adoption of VBC initiatives to improve health outcomes and lower costs. The four-year collaboration will add 170+ providers across four clinics to the Stellar platform to advance the quality of care for patients. The partnership keeps Stellar on track to hit 110,000 managed lives in Minnesota by end of year – 2.5x growth YOY in the state!
Stellar’s web-based, cloud-native, point-of-care platform leverages historical patient information to prompt primary care providers with granular action recommendations within their daily workflow to improve patient outcomes. Stellar will support NCC to offer real-time incentives tied to the completion of these high-value actions, rewarding specific providers and care team members within their ACO that are going above and beyond to deliver exceptional patient care to over 18,000 patients across Medicare and Medicaid lines of business. The partnership aligns with Stellar’s mission, to empower primary care practices to deliver value-based care that is payor-agnostic and always keep the patient top of mind.
NCC ACO expects a high level of engagement amongst providers and care teams across participating clinics. “Partnering with Stellar means putting actionable information in the hands of our providers and their teams to benefit our customers,” said Dr. Carolyn Ogland, President of the NCC and Chair of the NCC Board of Directors. “Using this technology, we give our team members a critical advantage in delivering tailored care to our community.”
PathologyWatch, a digital lab and pathology platform for dermatologists, has closed a $25 million Series B round. Among the investors who took part in the round were Ceros Capital Markets, Rock Creek Capital, Springtide Capital, Spark Growth Ventures, Blueprint Health, Blackbrook Management Group, and existing investors.
With the new funding, the company will broaden its outreach to dermatologists and conduct further research into skincare diagnostics and AI and plans to open labs in Texas, Florida and Arizona.
To read more, click here.
Prenosis, a precision diagnostics company seeking to improve clinical diagnosis with predictive intelligence, particularly for sepsis, announced this week that the Defense Threat Reduction Agency (DTRA), a U.S. Department of Defense agency that confronts emerging threats, awarded the company up to $4.3 million for further development of point-of-care technology for the early detection of sepsis for warfighters in the field.
The new development follows a collaboration deal with Roche Diagnostics earlier this year.
According to the World Health Organization, more than 11 million people die from sepsis worldwide annually, more than the deaths caused by all cancers combined. To read more, click here.
aptihealth, a health tech behavioral health provider, has closed a $50 million Series B funding round from Takeda Digital Ventures, Pivotal Life Sciences, Vista Credit Partners, Olive Tree Ventures, Claritas Capital, and What If Ventures. The company plans to use the fresh capital to expand investment in clinical science, technology, and services that make it easy, effective, and efficient for patients, providers, community organizations, and health plans to work together securely.
Picture: akindo, Getty Images
